2 Projects | 1 Researchers | $2,397,652 Invested
2023
ADmit Therapeutics S.L.
Marta Barrachina, PhD, MBA
MAP-AD, a revolutionary Methylation Profiling approach for early diagnosis of Alzheimer’s Disease
2019
ADmit Therapeutics S.L.
Marta Barrachina, PhD, MBA
ADmit Test: a new kit for an early Alzheimer's disease detection